From AVATAR Mice to Patients: RC48-ADC Exerted Promising Efficacy in Advanced Gastric Cancer With HER2 Expression
RC48-ADC is a novel humanized antibody specific for human epidermal growth factor receptor 2 (HER2)in conjugation with a microtubule inhibitor via a cleavable linker. This study was to evaluate the antitumor activity and mechanism of RC48-ADC in gastric cancer (GC) and explore the population that ma...
Saved in:
Main Authors: | Zuhua Chen (Author), Jiajia Yuan (Author), Yingying Xu (Author), Cheng Zhang (Author), Zhongwu Li (Author), Jifang Gong (Author), Yanyan Li (Author), Lin Shen (Author), Jing Gao (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2022-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A Novel Dual-Payload ADC for the Treatment of HER2+ Breast and Colon Cancer
by: Candice Maria Mckertish, et al.
Published: (2023) -
The Chemistry Behind ADCs
by: Vesela Kostova, et al.
Published: (2021) -
Antibody-drug conjugates (ADCs) may be a big breakthrough in gynecologic cancer treatment (II): Anti-HER2/neu
by: Peng-Hui Wang, et al.
Published: (2024) -
New antibody-drug conjugates (ADCs) in breast cancer-an overview of ADCs recently approved and in later stages of development
by: Kira-Lee Koster, et al.
Published: (2022) -
What is the Avatar? Fiction and Embodiment in Avatar-Based Singleplayer Computer Games. Revised and Commented Edition
by: Klevjer, Rune
Published: (2022)